Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

TABLE 1s. Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending January 15, 2022 (Week 02)
Reporting Area Invasive pneumococcal disease, all ages §
Confirmed Probable
Current weekPrevious 52 weeks Max †Cum YTD 2022 †Cum YTD 2021 †Current weekPrevious 52 weeks Max †Cum YTD 2022 †Cum YTD 2021 †
U.S. Residents, excluding U.S. Territories 103 376 539 326 1 14 16 6
New England 2 17 4 17 - 1 - -
Connecticut - 6 - 5 - 0 - -
Maine 2 7 3 3 - 0 - -
Massachusetts - 6 - 5 - 1 - -
New Hampshire - 2 - 3 - 1 - -
Rhode Island - 2 - - - 0 - -
Vermont - 2 1 1 - 0 - -
Middle Atlantic 38 52 105 44 1 6 6 2
New Jersey 8 9 17 11 - 3 - 2
New York (excluding New York City) 20 21 32 4 1 2 3 -
New York City 10 17 23 13 - 6 - -
Pennsylvania - 18 33 16 - 2 3 -
East North Central 7 64 126 44 - 4 5 1
Illinois N NC N N N NC N N
Indiana - 14 6 13 - 0 - -
Michigan - 13 19 10 - 2 1 1
Ohio - 41 82 18 - 3 4 -
Wisconsin 7 14 19 3 - 0 - -
West North Central 10 19 33 11 - 4 2 1
Iowa N NC N N N NC N N
Kansas - 0 - - - 0 - -
Minnesota - 0 - - - 0 - -
Missouri 8 15 27 7 - 2 2 1
Nebraska 2 7 4 2 - 0 - -
North Dakota - 2 2 - - 0 - -
South Dakota - 5 - 2 - 3 - -
South Atlantic 19 58 84 59 - 5 - 2
Delaware 1 5 2 1 - 0 - -
District of Columbia - 2 - - - 0 - -
Florida 18 26 38 12 - 3 - 2
Georgia - 17 17 28 - 0 - -
Maryland - 11 - 9 - 1 - -
North Carolina N NC N N N NC N N
South Carolina - 21 27 - - 3 - -
Virginia - 1 - - - 0 - -
West Virginia - 13 - 9 - 0 - -
East South Central 6 44 61 38 - 2 - -
Alabama 2 17 21 15 - 1 - -
Kentucky 1 8 5 2 - 2 - -
Mississippi 2 8 8 8 - 0 - -
Tennessee 1 26 27 13 - 0 - -
West South Central 17 56 46 28 - 3 1 -
Arkansas 4 10 10 1 - 0 - -
Louisiana 10 29 12 20 - 1 - -
Oklahoma N NC N N N NC N N
Texas 3 41 24 7 - 3 1 -
Mountain 3 91 72 78 - 2 1 -
Arizona - 42 40 37 - 1 - -
Colorado - 28 - 17 - 0 - -
Idaho N NC N N N NC N N
Montana 1 5 4 1 - 1 - -
Nevada - 10 3 9 - 1 - -
New Mexico 1 13 16 10 - 0 - -
Utah 1 12 9 2 - 1 1 -
Wyoming - 3 - 2 - 0 - -
Pacific 1 12 8 7 - 2 1 -
Alaska 1 11 8 5 - 2 1 -
California N NC N N N NC N N
Hawaii - 3 - 2 - 0 - -
Oregon N NC N N N NC N N
Washington N NC N N N NC N N
U.S. Territories - 1 - - - 0 - -
American Samoa N NC N N N NC N N
Commonwealth of Northern Mariana Islands - 0 - - - 0 - -
Guam - 0 - - - 0 - -
Puerto Rico - 1 - - - 0 - -
U.S. Virgin Islands - 0 - - - 0 - -
Non-U.S. Residents - 0 - - - 0 - -
Total 103 376 539 326 1 14 16 6
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • Max: Maximum — Maximum case count during the previous 52 weeks.
  • * Case counts for reporting years 2021 and 2022 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf.
  • †Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease.